Martine A Rothblatt United Therapeutics Corp (UTHR) insider trading activity

Martine A Rothblatt is Chairperson & CEO of UNITED THERAPEUTICS Corp. Currently has a direct ownership of 130 shares of UTHR, which is worth approximately $52,404. The most recent transaction as insider was on Mar 05, 2024, when has been sold 6,300 shares (Common Stock) at a price of $231.32 per share, resulting in proceeds of $1,457,316. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 130

0% 3M change

0% 12M change

Total Value Held $52,404

MARTINE A ROTHBLATT Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 05 2024	SELL Open market or private sale	$1,457,316 $231.32 p/Share	6,300 Reduced 97.98%	130 Common Stock
Mar 05 2024	BUY Exercise of conversion of derivative security	$815,787 $129.49 p/Share	6,300 Added 49.49%	6,430 Common Stock
Mar 04 2024	SELL Open market or private sale	$211,904 $231.59 p/Share	915 Reduced 87.56%	130 Common Stock
Mar 04 2024	BUY Exercise of conversion of derivative security	$118,483 $129.49 p/Share	915 Added 46.68%	1,045 Common Stock
Mar 01 2024	SELL Open market or private sale	$3,512,550 $234.17 p/Share	15,000 Reduced 99.14%	130 Common Stock
Mar 01 2024	BUY Exercise of conversion of derivative security	$1,942,350 $129.49 p/Share	15,000 Added 49.78%	15,130 Common Stock
May 02 2023	SELL Open market or private sale	$1,837,600 $229.7 p/Share	8,000 Reduced 98.4%	130 Common Stock
May 02 2023	BUY Exercise of conversion of derivative security	$904,640 $113.08 p/Share	8,000 Added 49.6%	8,130 Common Stock
May 01 2023	SELL Open market or private sale	$1,850,880 $231.36 p/Share	8,000 Reduced 98.4%	130 Common Stock
May 01 2023	BUY Exercise of conversion of derivative security	$904,640 $113.08 p/Share	8,000 Added 49.6%	8,130 Common Stock
Apr 28 2023	SELL Open market or private sale	$1,834,240 $229.28 p/Share	8,000 Reduced 98.4%	130 Common Stock
Apr 28 2023	BUY Exercise of conversion of derivative security	$904,640 $113.08 p/Share	8,000 Added 49.6%	8,130 Common Stock
Apr 27 2023	SELL Open market or private sale	$1,808,160 $226.02 p/Share	8,000 Reduced 98.4%	130 Common Stock
Apr 27 2023	BUY Exercise of conversion of derivative security	$904,640 $113.08 p/Share	8,000 Added 49.6%	8,130 Common Stock
Apr 26 2023	SELL Open market or private sale	$1,810,480 $226.31 p/Share	8,000 Reduced 98.4%	130 Common Stock
Apr 26 2023	BUY Exercise of conversion of derivative security	$904,640 $113.08 p/Share	8,000 Added 49.6%	8,130 Common Stock
Apr 25 2023	SELL Open market or private sale	$1,812,960 $226.62 p/Share	8,000 Reduced 98.4%	130 Common Stock
Apr 25 2023	BUY Exercise of conversion of derivative security	$904,640 $113.08 p/Share	8,000 Added 49.6%	8,130 Common Stock
Apr 24 2023	SELL Open market or private sale	$1,836,400 $229.55 p/Share	8,000 Reduced 98.4%	130 Common Stock
Apr 24 2023	BUY Exercise of conversion of derivative security	$904,640 $113.08 p/Share	8,000 Added 49.6%	8,130 Common Stock
Apr 21 2023	SELL Open market or private sale	$1,829,040 $228.63 p/Share	8,000 Reduced 98.4%	130 Common Stock
Apr 21 2023	BUY Exercise of conversion of derivative security	$904,640 $113.08 p/Share	8,000 Added 49.6%	8,130 Common Stock
Apr 20 2023	SELL Open market or private sale	$1,798,160 $224.77 p/Share	8,000 Reduced 98.4%	130 Common Stock
Apr 20 2023	BUY Exercise of conversion of derivative security	$904,640 $113.08 p/Share	8,000 Added 49.6%	8,130 Common Stock
Apr 19 2023	SELL Open market or private sale	$1,813,680 $226.71 p/Share	8,000 Reduced 98.4%	130 Common Stock

MAR

Martine A Rothblatt

Chairperson & CEO

Silver Spring, MD

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells UTHR shares.

Notify only if

Value

Insider Trading

Get notified when an United Therapeutics Corp insider buys or sells UTHR shares.

Notify only if

Operation

Value

Type

News

Receive news related to UNITED THERAPEUTICS Corp

Track Activities on UTHR

Account